Science4Beauty Raises 1.6 Million Euros | Startbase
Science4Beauty Raises 1.6 Million Euros | Startbase
摘要: Javascript is disabled in your browser
Startbase requires Javascript in order to display content.
Please check your browser settings and enable Java
正文
Javascript is disabled in your browser
Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.
Your browser is outdated and Startbase will not be displayed correctly.
Please use a modern web-browser like
Mozilla Firefox
Google Chrome
Microsoft Edge
.
Startbase.com
Magazine
Science4Beauty Raises 1.6 Million Euros
Science4Beauty Raises 1.6 Million Euros
1.6 million euros for biotech in the beauty market. Science4Beauty develops active ingredients based on recombinant proteins and is relying on a conotoxin for its first product.
Marc Nemitz
Warschau, 03. September 2026
Science4Beauty Magdalena Janczewska, Dr. Anna Mazurkiewicz-Pisarek, Alina Mazurkiewicz und Agata Stefanek
The Polish biotech startup Science4Beauty has closed a funding round totaling 1.6 million euros. The round was led by the Polish investor 4growth VC, with additional participation from Hard2beat and several
business angels
. The company plans to use the capital to drive its international expansion, expand its sales operations, and develop additional bioactive molecules for dermatology and aesthetic medicine.
At the heart of the technology is a proprietary platform for the development and production of recombinant proteins and bioactive peptides. Its most prominent product to date is based on an active ingredient that mimics the mechanism of conotoxins found in the venom of sea snails and is used for the non-invasive reduction of facial wrinkles.
Biotechnology Meets the Beauty Market
Science4Beauty was founded in 2020 by Magdalena Janczewska, Dr. Anna Mazurkiewicz-Pisarek, Alina Mazurkiewicz, and Agata Stefanek. Prof. Tomasz Ciach supports the company as a scientific advisor.
The startup operates its own certified genetic engineering laboratory, where recombinant proteins and bioactive peptides are developed, produced, and purified. The technology is